Skip to NavigationSkip to content

Takeda to cut 2,800 jobs

Published on 19/01/12 at 10:39am
Takeda image
Takeda's HQ in Tokyo

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed.

The consolidation plans will account for 2,100 job losses in Europe and 700 in the US, amounting to around 10% of its workforce.

Takeda’s plans which will come to fruition by the end of fiscal 2015 hope to streamline its operations across the board, following September’s €9.6 billion acquisition.

Takeda’s President and chief executive Yasuchika Hasegawa, said: “While our combined operations in more than 70 countries are more complementary than overlapping, there are a number of areas where we will need to make changes to ensure efficient and flexible operations moving forward."

The company said it will achieve cost synergies of approximately 200 billion yen as it reduces its R&D and commercial functions. The cost to implement the changes is set at 70 billion yen.

"The combination of Takeda and Nycomed brought together Takeda's strong presence in the Japanese and US markets, with the legacy Nycomed business infrastructure in Europe and high-growth emerging markets," Hasegawa added.

Takeda’s ‘2011-2013 Mid-Range Plan’ states it still intends to invest strongly in R&D and will focus on core therapeutic areas.

Between them the companies’ therapy areas include metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management. 

Brett Wells

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches